These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24396426)

  • 1. FOLFOX versus EOX as a neoadjuvant chemotherapy regimen for patients with advanced gastric cancer.
    Chen W; Shen J; Pan T; Hu W; Jiang Z; Yuan X; Wang L
    Exp Ther Med; 2014 Feb; 7(2):461-467. PubMed ID: 24396426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of preoperative chemotherapy regimens in patients with initially unresectable locally advanced gastric adenocarcinoma: capecitabine and oxaliplatin (XELOX) or with epirubicin (EOX).
    Wang Y; Zhuang RY; Yu YY; Yu S; Hou J; Ji Y; Sun YH; Shen KT; Shen ZB; Liu FL; Zhao NQ; Liu TS
    Oncotarget; 2016 Nov; 7(46):76298-76307. PubMed ID: 27602586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined perioperative EOX chemotherapy and postoperative chemoradiotherapy for locally advanced gastric cancer.
    He Q; Zhao J; Yuan J; Gong Z; Yi T
    Mol Clin Oncol; 2017 Aug; 7(2):211-216. PubMed ID: 28781787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
    Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial.
    Ochenduszko S; Puskulluoglu M; Konopka K; Fijorek K; Urbanczyk K; Budzynski A; Matlok M; Lazar A; Sinczak-Kuta A; Pedziwiatr M; Krzemieniecki K
    Med Oncol; 2015 Oct; 32(10):242. PubMed ID: 26354521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Efficacy of Aspirin Plus EOX vs. EOX Alone in Patients with Locally Advanced and Metastatic Gastric Cancer: a Randomized Clinical Trial.
    Jafa E; L C; Nisha Y; Kate V; Kayal S; Ganesh RN; V C S; Ganesan P; Penumadu P; Dubashi B
    J Gastrointest Cancer; 2023 Jun; 54(2):642-650. PubMed ID: 35842566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Efficacy and Safety of Modified Docetaxel, Cisplatin, and 5-Fluorouracil Vs. Epirubicin, Oxaliplatin, and Capecitabine Regimen in the Advanced Gastric Cancer: A Randomized Controlled Clinical Trial.
    Ahmadzadeh A; Seyedian SS; Valizadeh A; Soleimani M; Nazari P; Hamidi H
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):727-732. PubMed ID: 32212800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Supplementary Omegaven® on the Clinical Outcome of Patients With Advanced Esophagogastric Adenocarcinoma Receiving Palliative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy: A Phase II clinical trial.
    Eltweri AM; Thomas AL; Chung WY; Morgan B; Thompson J; Dennison AR; Bowrey DJ
    Anticancer Res; 2019 Feb; 39(2):853-861. PubMed ID: 30711967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epirubicin, oxaliplatin, and capectabine is just as "MAGIC"al as epirubicin, cisplatin, and fluorouracil perioperative chemotherapy for resectable locally advanced gastro-oesophageal cancer.
    Sirohi B; Barreto SG; Singh A; Batra S; Mittra A; Rastogia S; Ramadwar M; Shetty N; Goel M; Shrikhande SV
    J Cancer Res Ther; 2014; 10(4):866-70. PubMed ID: 25579520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma.
    Sahin U; Türeci Ö; Manikhas G; Lordick F; Rusyn A; Vynnychenko I; Dudov A; Bazin I; Bondarenko I; Melichar B; Dhaene K; Wiechen K; Huber C; Maurus D; Arozullah A; Park JW; Schuler M; Al-Batran SE
    Ann Oncol; 2021 May; 32(5):609-619. PubMed ID: 33610734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
    Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
    Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of FOLFOX and DOF regimens as first-line treatment in East Asian patients with advanced gastric cancer.
    Liu M; Hu G; Wang Y; Guo J; Liu L; Han X; Wang Z
    Onco Targets Ther; 2018; 11():375-381. PubMed ID: 29398919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
    Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
    Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of FOLFOX and Modified DCF Chemotherapy Regimen in Patients with Advanced Gastric Adenocarcinoma.
    Pourghasemian M; Danandeh Mehr A; Molaei M; Habibzadeh A
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2337-2341. PubMed ID: 32856863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features and prognosis analysis of 21 gastric cancer patients with pathological complete response after neoadjuvant chemotherapy].
    Peng L; Yang W; Zhang Z; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1168-1173. PubMed ID: 29130233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost minimization analysis of capecitabine versus 5-fluorouracil-based treatment for gastric cancer patients in Hong Kong.
    Zhou KR; Cheng A; Ng WT; Kwok TY; Yip EY; Yao R; Leung PY; Lee VW
    J Med Econ; 2017 May; 20(5):541-548. PubMed ID: 28277030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer.
    Jonker D; Rumble RB; Maroun J;
    Curr Oncol; 2006 Oct; 13(5):173-84. PubMed ID: 22792014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy in Locally Advanced Gastric Cancer: Safety and Feasibility in an Interim Survival Analysis.
    Ostwal V; Sahu A; Ramaswamy A; Sirohi B; Bose S; Talreja V; Goel M; Patkar S; Desouza A; Shrikhande SV
    J Gastric Cancer; 2017 Mar; 17(1):21-32. PubMed ID: 28337360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen.
    Gómez-Martin C; Sánchez A; Irigoyen A; Llorente B; Pérez B; Serrano R; Safont MJ; Falcó E; Lacasta A; Reboredo M; Aparicio J; Dueñas R; Muñoz ML; Regueiro P; Sanchez-Viñes E; López RL
    Clin Transl Oncol; 2012 Sep; 14(9):689-97. PubMed ID: 22855151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative chemotherapy versus neoadjuvant chemoradiation for patients with adenocarcinoma of the distal esophagus in Austria: a retrospective analysis.
    Koch OO; Weitzendorfer M; Varga M; Tschoner A; Partl R; Perathoner A; Gehwolf P; Kapp KS; Függer R; Öfner D; Emmanuel K
    World J Surg Oncol; 2019 Aug; 17(1):146. PubMed ID: 31426805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.